financetom
Business
financetom
/
Business
/
Morningstar Insider Sold Shares Worth $796,106, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morningstar Insider Sold Shares Worth $796,106, According to a Recent SEC Filing
Mar 11, 2026 3:48 AM

05:10 PM EST, 02/11/2026 (MT Newswires) -- Joseph D Mansueto, 10% Owner, Director, Executive Chairman, on February 09, 2026, sold 4,867 shares in Morningstar ( MORN ) for $796,106. Following the Form 4 filing with the SEC, Mansueto has control over a total of 14,645,377 common shares of the company, with 8,212,442 shares held directly and 6,432,935 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1289419/000132406926000006/xslF345X05/wk-form4_1770847336.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing
Blue Bird Insider Sold Shares Worth $767,260, According to a Recent SEC Filing
Sep 2, 2025
11:25 AM EDT, 09/02/2025 (MT Newswires) -- Phil Horlock, Director, on August 28, 2025, sold 13,000 shares in Blue Bird ( BLBD ) for $767,260. Following the Form 4 filing with the SEC, Horlock has control over a total of 240,766 common shares of the company, with 240,766 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1589526/000157947725000018/xslF345X05/wk-form4_1756826178.xml Price: 57.75, Change: -0.64, Percent Change:...
Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced
Update: Arrowhead Pharmaceuticals Shares Rise After Novartis Licensing Deal Announced
Sep 2, 2025
11:25 AM EDT, 09/02/2025 (MT Newswires) -- (Updates to include Arrowhead's stock movement in the headline and the first paragraph.) Arrowhead Pharmaceuticals ( ARWR ) shares rose 9.2% in recent Tuesday trading after the company announced a global licensing and collaboration agreement for its ARO-SNCA preclinical stage siRNA therapy to treat synucleinopathies, including Parkinson's disease, with Novartis ( NVS )...
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
Sep 2, 2025
Nukkleus Inc. ( NUKK ) shares soared on Tuesday after the company said it will acquire Israel-based Tiltan Software Engineering Ltd. in a $14 million deal. The acquisition, to be paid in a mix of cash and stock, is expected to close following regulatory approval and audited financials. The announcement underscores growing demand for AI-powered simulation and GPS-denied navigation tools...
Update: Ionis Pharma Shares Rise After Reporting 'Positive' Olezarsen Data in Severe Hypertriglyceridemia
Update: Ionis Pharma Shares Rise After Reporting 'Positive' Olezarsen Data in Severe Hypertriglyceridemia
Sep 2, 2025
11:26 AM EDT, 09/02/2025 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.) Ionis Pharmaceuticals ( IONS ) shares were up more than 33% in recent Tuesday trading after the company reported topline data from phase 3 studies of olezarsen, which showed that the drug candidate significantly reduced fasting triglycerides and acute pancreatitis events in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved